牙周炎与非酒精性脂肪性肝病相关性的研究进展

doi:10.13591/j.cnki.kqyx.2023.07.013

摘要/Abstract

摘要：

牙周炎是一类以牙周支持组织进行性破坏为表现的慢性疾病,相关研究表明以牙龈卟啉单胞菌为主要致病菌的牙周炎与非酒精性脂肪性肝病的发生发展有一定联系,但两者间的关系仍不明确。本文将从流行病学、生物学机制等方面进行综述,探究两种疾病的相关性,进一步提供可能的研究方向。

关键词: 牙周炎, 非酒精性脂肪性肝病, 牙龈卟啉单胞菌

Abstract:

Periodontitis is a kind of chronic disease characterized by progressive destruction of periodontal supporting tissue. Related studies have shown that periodontitis with Porphyromonas gingivalis as the main pathogen is related to the occurrence and development of non-alcoholic fatty liver disease, but the relationship between the two is still unclear. This article will review the epidemiology, biological mechanism and other aspects to explore the correlation between the two diseases and further provide possible research directions.

Key words: periodontitis, non-alcoholic fatty liver disease, Porphyromonas gingivalis

中图分类号:

R781.4

李少华, 林晓萍. 牙周炎与非酒精性脂肪性肝病相关性的研究进展[J]. 口腔医学, 2023, 43(7): 652-656.

LI Shaohua, LIN Xiaoping. Research progress of the relationship between periodontitis and non-alcoholic fatty liver disease[J]. Stomatology, 2023, 43(7): 652-656.

参考文献 41

[1]	European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. J Hepatol, 2016, 64(6):1388-1402. doi: 10.1016/j.jhep.2015.11.004 pmid: 27062661
[2]	Liu JY, Tian Y, Fu X, et al. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: Systematic review and meta-analysis[J]. Chin Med J (Engl), 2022, 135(14):1682-1691.
[3]	Tan DJH, Ng CH, Lin SY, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis[J]. Lancet Oncol, 2022, 23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X pmid: 35255263
[4]	Weintraub JA, Lopez Mitnik G, Dye BA. Oral diseases associated with nonalcoholic fatty liver disease in the United States[J]. J Dent Res, 2019, 98(11):1219-1226. doi: 10.1177/0022034519866442 pmid: 31369716
[5]	Iwasaki T, Hirose A, Azuma T, et al. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan[J]. Sci Rep, 2018, 8(1):7496. doi: 10.1038/s41598-018-25857-z pmid: 29760403
[6]	Helenius-Hietala J, Suominen AL, Ruokonen H, et al. Periodontitis is associated with incident chronic liver disease-A population-based cohort study[J]. Liver Int, 2019, 39(3):583-591. doi: 10.1111/liv.13985 pmid: 30300961
[7]	Shin HS. Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study[J]. J Periodontol, 2020, 91(4):524-532. doi: 10.1002/jper.v91.4
[8]	Kim JY, Lee GN, Song HC, et al. Association between fatty liver index and periodontitis: The Korea national health and nutrition examination survey[J]. Sci Rep, 2020, 10(1):3805. doi: 10.1038/s41598-020-60797-7
[9]	Surlin P, Didilescu AC, Lazar L, et al. Evaluation through the optical coherence tomography analysis of the influence of non-alcoholic fatty liver disease on the gingival inflammation in periodontal patients[J]. Diabetes Metab Syndr Obes, 2021, 14:2935-2942. doi: 10.2147/DMSO.S310314
[10]	Alazawi W, Bernabe E, Tai D, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease[J]. PLoS One, 2017, 12(12):e0185902. doi: 10.1371/journal.pone.0185902
[11]	Kuroe K, Furuta M, Takeuchi K, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol, 2021, 48(3):368-377. doi: 10.1111/jcpe.13415 pmid: 33368494
[12]	Cecil JD, Sirisaengtaksin N, O'brien-Simpson NM, et al. Outer membrane vesicle-host cell interactions[J]. Microbiol Spectr, 2019, 7(1):10.1128/microbiolspec.PSIB-10.1128/microbiolspec.0001-2018. doi: 10.1128/microbiolspec.PSIB-10.1128/microbiolspec.0001-2018
[13]	Seyama M, Yoshida K, Yoshida K, et al. Outer membrane vesicles of Porphyromonas gingivalis attenuate insulin sensitivity by delivering gingipains to the liver[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(6):165731. doi: 10.1016/j.bbadis.2020.165731
[14]	Yue YY, Liu XC, Li Y, et al. The role of TLR4/MyD88/NF-κB pathway in periodontitis-induced liver inflammation of rats[J]. Oral Dis, 2021, 27(4):1012-1021. doi: 10.1111/odi.v27.4
[15]	Ding LY, Liang LZ, Zhao YX, et al. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways[J]. Oral Dis, 2019, 25(7):1789-1797. doi: 10.1111/odi.v25.7
[16]	Cai J, Chen JM, Guo HX, et al. Recombinant fimbriae protein of Porphyromonas gingivalis induces an inflammatory response via the TLR4/NF-κB signaling pathway in human peripheral blood mononuclear cells[J]. Int J Mol Med, 2019, 43(3):1430-1440.
[17]	Qiao WW, Wang CN, Huang WS, et al. Peroxisome proliferator-activated receptor γ plays dual roles on experimental periodontitis in rats[J]. J Clin Periodontol, 2018, 45(5):514-523. doi: 10.1111/jcpe.12891 pmid: 29574908
[18]	Lu Z, Li Y, Yu H, et al. High-fat diet-induced metabolic syndrome increases ligature-induced alveolar bone loss in mice[J]. Oral Dis, 2021:2021Dec16.
[19]	Karunakaran U, Elumalai S, Moon JS, et al. CD36 signal transduction in metabolic diseases: Novel insights and therapeutic targeting[J]. Cells, 2021, 10(7):1833. doi: 10.3390/cells10071833
[20]	Yang Z, Huang XP, Zhang JY, et al. Hepatic DKK₁-driven steatosis is CD36 dependent[J]. Life Sci Alliance, 2022, 6(1):e202201665.
[21]	Zhang C, Luo XH, Chen JR, et al. Osteoprotegerin promotes liver steatosis by targeting the ERK-PPAR-γ-CD36 pathway[J]. Diabetes, 2019, 68(10):1902-1914. doi: 10.2337/db18-1055 pmid: 31292134
[22]	Hajri T, Zaiou M, Fungwe TV, et al. Epigenetic regulation of peroxisome proliferator-activated receptor gamma mediates high-fat diet-induced non-alcoholic fatty liver disease[J]. Cells, 2021, 10(6):1355. doi: 10.3390/cells10061355
[23]	Ahn JS, Yang JW, Oh SJ, et al. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway[J]. BMB Rep, 2021, 54(6):323-328. doi: 10.5483/BMBRep.2021.54.6.050
[24]	Ni J, Chen L, Zhong SL, et al. Influence of periodontitis and scaling and root planing on insulin resistance and hepatic CD36 in obese rats[J]. J Periodontol, 2018, 89(4):476-485. doi: 10.1002/JPER.17-0115 pmid: 29520779
[25]	Vasconcelos ACCG, Vasconcelos DFP, Pereira da Silva FR, et al. Periodontitis causes abnormalities in the liver of rats[J]. J Periodontol, 2019, 90(3):295-305. doi: 10.1002/JPER.18-0226 pmid: 30216457
[26]	Mester A, Ciobanu L, Taulescu M, et al. Periodontal disease may induce liver fibrosis in an experimental study on Wistar rats[J]. J Periodontol, 2019, 90(8):911-919. doi: 10.1002/JPER.18-0585 pmid: 30689209
[27]	dos Santos Carvalho J, Cardoso Guimarães Vasconcelos AC, Herlany Pereira Alves E, et al. Steatosis caused by experimental periodontitis is reversible after removal of ligature in rats[J]. J Periodontal Res, 2017, 52(5):883-892. doi: 10.1111/jre.12459 pmid: 28504459
[28]	Andrade RSB, França LFC, Pessoa LDS, et al. High-fat diet aggravates the liver disease caused by periodontitis in rats[J]. J Periodontol, 2019, 90(9):1023-1031. doi: 10.1002/JPER.18-0564 pmid: 30801719
[29]	Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol, 2013, 48(11):1259-1270. doi: 10.1007/s00535-012-0738-1 pmid: 23307045
[30]	Zhu XP, Bian H, Wang L, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway[J]. Free Radic Biol Med, 2019, 141:192-204. doi: 10.1016/j.freeradbiomed.2019.06.019
[31]	Xing T, Liu YJ, Cheng HX, et al. Ligature induced periodontitis in rats causes gut dysbiosis leading to hepatic injury through SCD1/AMPK signalling pathway[J]. Life Sci, 2022, 288:120162. doi: 10.1016/j.lfs.2021.120162
[32]	Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by Porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice[J]. Front Microbiol, 2018, 9:2470. doi: 10.3389/fmicb.2018.02470 pmid: 30405551
[33]	Jiang PR, Zheng WY, Sun XN, et al. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice[J]. Int J Biol Macromol, 2021, 167:1587-1597. doi: 10.1016/j.ijbiomac.2020.11.116
[34]	Symmank J, Appel S, Bastian JA, et al. Hyperlipidemic conditi-ons impact force-induced inflammatory response of human periodontal ligament fibroblasts concomitantly challenged with P. gingivalis-LPS[J]. Int J Mol Sci, 2021, 22(11):6069. doi: 10.3390/ijms22116069
[35]	Nagasaki A, Sakamoto S, Arai T, et al. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH[J]. J Clin Periodontol, 2021, 48(10):1367-1378. doi: 10.1111/jcpe.v48.10
[36]	Kamata Y, Kessoku T, Shimizu T, et al. Efficacy and safety of PERIO dontal treatment versus usual care for Nonalcoholic liver disease: Protocol of the PERION multicenter, two-arm, open-label, randomized trial[J]. Trials, 2020, 21(1):291. doi: 10.1186/s13063-020-4201-y pmid: 32293522
[37]	柴红波, 梁守建, 牛玉明, 等. 大黄素下调牙周组织细胞核因子-κB是治疗中、重度慢性牙周炎机制之一[J]. 实用口腔医学杂志, 2020, 36(3):517-520.
[38]	谷冬华, 郭宁, 赵晓丹, 等. 联用大黄、黄芩对牙周炎SD大鼠炎性因子的抑制作用及对骨组织再生的促进效应研究[J]. 口腔医学, 2020, 40(8):692-697.
[39]	王玉, 杨雪, 夏鹏飞, 等. 大黄化学成分、药理作用研究进展及质量标志物的预测分析[J]. 中草药, 2019, 50(19):4821-4837.
[40]	崔祥, 陶金华, 江曙, 等. 小檗碱与肠道菌群的相互作用研究[J]. 中国微生态学杂志, 2017, 29(12):1373-1377.
[41]	吴松, 张文娟, 崔茸茸, 等. 小檗碱对牙周炎大鼠的细胞因子水平、氧化应激和炎症性骨溶解的实验研究[J]. 现代生物医学进展, 2022, 22(5):814-817, 851.